This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| ciguatera | |
|---|---|
| Name | Ciguatera |
| Field | Toxicology |
| Symptoms | Nausea, vomiting, diarrhea, paresthesia, temperature reversal, myalgia |
| Complications | Chronic neuropathy, cognitive complaints |
| Onset | Minutes to 48 hours |
| Duration | Days to months |
| Causes | Fish-borne dinoflagellate-derived toxins |
| Risks | Tropical reef fish consumption, reef disturbance, travel to tropics |
| Diagnosis | Clinical, toxin assays |
| Differential | Scombroid poisoning, paralytic shellfish poisoning, Guillain–Barré syndrome |
| Prevention | Fish avoidance, monitoring programs |
ciguatera Ciguatera is a seafood-borne toxic illness caused by ingestion of fish that have bioaccumulated marine microalgal toxins. It typically occurs after eating reef-associated predatory fish and presents with a combination of gastrointestinal, neurological, and cardiovascular features. Outbreaks affect coastal communities, travelers, and fisheries, prompting surveillance by public health agencies and research by institutions studying marine toxicology.
Ciguatera is associated with consumption of reef fish such as barracuda, grouper, snapper, amberjack, and moray eel, and has been studied by agencies including the World Health Organization, Centers for Disease Control and Prevention, and regional ministries of health. Historical reports date from early maritime explorers and have influenced fisheries management in regions like the Caribbean Sea, Gulf of Mexico, Indian Ocean, and South Pacific Ocean. Research into toxin origins and food web dynamics involves institutions such as the Smithsonian Institution, Scripps Institution of Oceanography, and universities including University of Miami, University of Queensland, and James Cook University. International efforts to monitor seafood safety include programmes by the Food and Agriculture Organization and collaborations with regional laboratories.
The illness results from consumption of fish that have accumulated polyether toxins produced by benthic dinoflagellates in the genus Gambierdiscus. Investigation into toxin chemistry has been led by laboratories at Scripps Institution of Oceanography, Monash University, and Harvard University; compounds include ciguatoxins that activate voltage-gated sodium channels in nerve and muscle membranes. Molecular work linking toxin structure to function has involved researchers affiliated with Max Planck Society and National Institutes of Health laboratories. Ecological drivers such as coral reef degradation, algal blooms, cyclones, and tourism-related disturbance—studied by groups like University of Hawaii and Woods Hole Oceanographic Institution—alter Gambierdiscus abundance and increase transfer through trophic levels to predators such as Epinephelus, Lutjanus, and Sphyraena species. Analytical detection methods using mass spectrometry and bioassays have been advanced by teams at European Food Safety Authority, FDA, and academic centers.
Ciguatera is endemic in tropical and subtropical regions, with high incidence reported from the Caribbean Sea, Florida Keys, Hawaii, French Polynesia, Fiji, Tonga, Bahamas, and Seychelles. Surveillance reports by the Centers for Disease Control and Prevention and national public health institutes show variable underreporting; outbreaks have been documented in travel medicine literature and case series from hospitals in Miami, Honolulu, Papeete, and Suva. Globalization of seafood trade and transoceanic shipping means cases have been exported to temperate regions including ports in Europe and Japan, prompting food safety alerts by the European Commission and Ministry of Health, Labour and Welfare (Japan). Epidemiologists from institutions such as LSHTM and Johns Hopkins Bloomberg School of Public Health analyze risk factors including fish size, species, seasonality, and environmental change.
Patients present within minutes to 48 hours with acute gastrointestinal symptoms (nausea, vomiting, diarrhea), often followed by neurological features including paresthesia, dysesthesia, reversal of hot–cold sensation, myalgia, and fatigue. Cardiovascular manifestations such as bradycardia and hypotension may require emergency care; case reports and review articles have appeared in journals linked to Mayo Clinic, Cleveland Clinic, and university hospitals. Diagnosis is primarily clinical, informed by recent fish consumption and regional exposure; laboratory confirmation uses toxin assays (LC-MS/MS) developed by reference labs associated with FDA, European Food Safety Authority, and university research centers. Differential diagnosis includes other marine toxin syndromes and neurologic disorders treated in tertiary centers like Johns Hopkins Hospital and Massachusetts General Hospital.
Management is largely supportive and symptomatic. Intravenous fluids and antiemetics are used for dehydration and gastrointestinal distress; cardiac monitoring and atropine may be required for bradyarrhythmias, guided by emergency departments such as those at Royal Prince Alfred Hospital and St Thomas' Hospital. Neuropathic symptoms may respond to agents studied in pain clinics at Mayo Clinic and UCL Hospitals, including gabapentin and amitriptyline. Mannitol infusion has been trialed in randomized and observational studies conducted by teams at University of the West Indies and University of Hawaii with mixed results; clinical guidance varies among bodies like the World Health Organization and national treatment protocols. Rehabilitation for prolonged deficits is provided by neurology and rehabilitation services at institutions including Royal National Hospital for Neurology and Neurosurgery.
Prevention focuses on avoiding high-risk species and large reef predators, public education campaigns by ministries of health and tourism boards in affected territories, and fishery management by agencies such as NOAA and regional fisheries organizations. Monitoring programmes use toxin screening at ports and laboratories operated by Food and Agriculture Organization partner institutions and national public health laboratories. Travel advisories from consular services, seafood certification schemes promoted by organizations like Marine Stewardship Council, and research into early warning systems by Plymouth Marine Laboratory and CSIRO aim to reduce incidence. Community engagement in reef conservation, studied by Conservation International and The Nature Conservancy, addresses underlying ecological drivers.
Category:Marine toxicology